Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Theranica Ltd
Minute Insight: Theranica’s Wearable Earns Expanded FDA Clearance For Preventing Migraines
Theranica’s expanded US FDA clearance allows the company to market its prescription-based wearable as both an acute and preventive treatment for migraine headaches.
US Medicare Creates New Code For Theranica’s Headache Device
Medicare beneficiaries suffering from migraines will soon have access to an innovate drug-free treatment at the touch of their smartphones.
CMS Announces Virtual Meetings To Discuss HCPCS Codes
The US Centers for Medicare & Medicaid Services (CMS) has announced the July schedule for its virtual Healthcare Common Procedure Coding System (HCPCS) public meetings.
Theranica’s Smartphone-Controlled Migraine Device Earns FDA De Novo
The FDA granted a de novo clearance to Theranica’s Nerivio Migra smartphone-controlled remote electrical neuromodulation device for acute treatment of migraine headaches.
- Digital Health
- Rehabilitation Equipment and Devices
- Other Names / Subsidiaries
- Siano Mobile Silicon
- Theranica Bio-Electronics Ltd.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.